World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00311259
Date of registration: 03/04/2006
Prospective Registration: Yes
Primary sponsor: University Hospital, Gentofte, Copenhagen
Public title: Melatonin Treatment and Inflammation, Oxidative Stress and Autonomic Function in Connection With Surgery
Scientific title:
Date of first enrolment: May 2006
Target sample size: 40
Recruitment status: Not yet recruiting
URL:  http://clinicaltrials.gov/show/NCT00311259
Study type:  Observational
Study design:  Allocation: Random Sample, Time Perspective: Cross-Sectional  
Phase: 
Countries of recruitment
Denmark
Contacts
Name:     Bülent Kücükakin
Address: 
Telephone:
Email:
Affiliation:  Department of Surgical Gastroenterology, University Hospital of Copenhagen in Gentofte
Name:     Bülent Kücükakin
Address: 
Telephone: +45 39978224
Email: bulkuc01@gentoftehosp.kbhamt.dk
Affiliation: 
Name:     Bülent Kücükakin
Address: 
Telephone: +45 3997824
Email: bulkuc01@gentoftehosp.kbhamt.dk
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- indikation for laparoscopic cholecystectomy

- women between 18 and 70 years old

Exclusion Criteria:

- men

- acute cholecystectomy

- pancreatitis

- renal insufficient

- well-known liver insufficient

- cardiovascular disease (arrhythmia, well-known ischaemic heart disease)

- drug therapy (digoxin, Ca-antagonist, amiodaron, beta-blocker)

- anticoagulation therapy (marevan and marcoumar)

- praeoperative therapy with opioid, anxiolytica and hypnotica)

- well-known sleep disease

- endocrine disease in drug therapy (diabetes mellitus, thyroid disease)

- daily alcohol consumption (more than 5 drinks)

- bad compliance (language difficulty, mental problems etc.)

- pregnancy and breast-feeding

- lack of written consent



Age minimum: 18 Years
Age maximum: 70 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Inflammatory Stress
Myocardial Ischaemia
Oxidative Stress
Intervention(s)
Drug: Laktose
Drug: Melatonin (drug)
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
2612-3108
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history